Dynamic Technology Lab Private LTD Enanta Pharmaceuticals Inc Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$40.77 - $53.73 $14,677 - $19,342	-360 Reduced 4.84%	7,080 $329,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $359,277 - $530,248	7,440 New	7,440 $386,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $347,011 - $458,740	-6,190 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $372,576 - $602,720	6,190 New	6,190 $463,000
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $247,070 - $295,846	-3,039 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$69.08 - $105.66 $209,934 - $321,100	3,039 New	3,039 $290,000
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $353,998 - $458,125	-5,412 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $462,509 - $683,914	5,412 New	5,412 $463,000
Q1 2018 May 14, 2018	SELL	$57.91 - $92.15 $419,268 - $667,166	-7,240 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$45.65 - $59.37 $330,506 - $429,838	7,240	7,240 $425,000

110

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $106M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.